PE11399A1 - COMBINATION OF LORATADINE AND A DECONESCENTANT FOR THE TREATMENT OF ASTHMA - Google Patents
COMBINATION OF LORATADINE AND A DECONESCENTANT FOR THE TREATMENT OF ASTHMAInfo
- Publication number
- PE11399A1 PE11399A1 PE1997000968A PE00096897A PE11399A1 PE 11399 A1 PE11399 A1 PE 11399A1 PE 1997000968 A PE1997000968 A PE 1997000968A PE 00096897 A PE00096897 A PE 00096897A PE 11399 A1 PE11399 A1 PE 11399A1
- Authority
- PE
- Peru
- Prior art keywords
- patient
- asthma
- loratadine
- combination
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
Abstract
SE REFIERE AL USO COMBINADO DEL ANTIHISTAMINICO ANTISEDANTE LORATADINA Y DE UN DESCONGESTIONANTE PARA LA MANUFACTURA DE UN MEDICAMENTO PARA MEJORAR LA FUNCION PULMONAR DE UN PACIENTE QUE PADECE ASMA INCLUYENDO LA ADMINISTRACION AL PACIENTE DE UN TRATAMIENTO HABITUAL PARA LA RINITIS; EN DONDE DICHO DESCONGESTIVO SE SELECCIONA DE FENILPROPANOLAMINA, EFEDRINA, FENILEFRINA, PSEUDOEFEDRINA O UNA COMBINACION DE LAS MISMAS. SE MUESTRA QUE EL USO DE ANTIHISTAMINICOS QUE ERA CONTRAINDICADO SI EL PACIENTE TENIA ASMA, TENDRIA UN EFECTO BENEFICIOSO EN EL PACIENTE ASMATICO, INDEPENDIENTE SI EL PACIENTE PADECE O NO PADECE RINITISIT REFERS TO THE COMBINED USE OF THE ANTI-HISTAMINE ANTISEDANT LORATADINE AND A DECONSTRUCTANT FOR THE MANUFACTURE OF A MEDICINAL PRODUCT TO IMPROVE THE LUNG FUNCTION OF A PATIENT WHO SUFFERS FROM ASTHMA INCLUDING ADMINISTRATION TO THE PATIENT OF A HABITUAL TREATMENT; WHERE SAID DECONGESTIVE IS SELECTED FROM PHENYL PROPANOLAMINE, EPHEDRINE, PHENYLEPHRINE, PSEUDOEFEDRINE OR A COMBINATION OF THE SAME. IT IS SHOWN THAT THE USE OF ANTIHISTAMINES THAT WAS CONTRAINDICATED IF THE PATIENT HAD ASTHMA, WOULD HAVE A BENEFICIAL EFFECT ON THE ASTHMATIC PATIENT, INDEPENDENT IF THE PATIENT SUFFERS OR DOESN'T HAVE RHINITIS
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US73966996A | 1996-10-31 | 1996-10-31 |
Publications (1)
Publication Number | Publication Date |
---|---|
PE11399A1 true PE11399A1 (en) | 1999-02-09 |
Family
ID=24973307
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE1997000968A PE11399A1 (en) | 1996-10-31 | 1997-10-29 | COMBINATION OF LORATADINE AND A DECONESCENTANT FOR THE TREATMENT OF ASTHMA |
Country Status (21)
Country | Link |
---|---|
EP (1) | EP0941091A1 (en) |
JP (1) | JP2000505104A (en) |
KR (1) | KR20000052922A (en) |
CN (1) | CN1235545A (en) |
AR (1) | AR008908A1 (en) |
AU (1) | AU731756B2 (en) |
BR (1) | BR9712705A (en) |
CA (1) | CA2268546A1 (en) |
CO (1) | CO4910128A1 (en) |
CZ (1) | CZ150999A3 (en) |
HU (1) | HUP9904075A3 (en) |
ID (1) | ID23431A (en) |
IL (1) | IL129662A0 (en) |
NO (1) | NO992062D0 (en) |
NZ (1) | NZ335078A (en) |
PE (1) | PE11399A1 (en) |
PL (1) | PL333056A1 (en) |
SK (1) | SK54599A3 (en) |
TR (1) | TR199901003T2 (en) |
WO (1) | WO1998018470A1 (en) |
ZA (1) | ZA979731B (en) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6270796B1 (en) * | 1997-10-29 | 2001-08-07 | Robert E. Weinstein | Antihistamine/decongestant regimens for treating rhinitis |
US6132758A (en) | 1998-06-01 | 2000-10-17 | Schering Corporation | Stabilized antihistamine syrup |
IT1303671B1 (en) * | 1998-07-28 | 2001-02-23 | Nicox Sa | SALTS OF NITRIC ACID WITH ACTIVE DRUGS IN THE TREATMENT OF DISEASES OF THE RESPIRATORY SYSTEM |
WO2000015226A1 (en) * | 1998-09-10 | 2000-03-23 | Schering Corporation | Antihistamines for treating non-infective sinusitis or otitis media |
US6521254B2 (en) | 1998-12-07 | 2003-02-18 | J-Med Pharmaceuticals, Inc. | Single-dose antihistamine/decongestant formulations for treating rhinitis |
CN1161112C (en) * | 1999-02-23 | 2004-08-11 | 株式会社柳韩洋行 | Pharmaceutical capsule compositions containing loratadine and pseudoephedrine |
KR100505899B1 (en) * | 1999-02-23 | 2005-08-01 | 주식회사유한양행 | Pharmaceutical capsule compositions containing loratadine and pseudoephedrine |
WO2000057880A1 (en) * | 1999-03-29 | 2000-10-05 | Schering Corporation | Methods and compositions for treating allergic and related disorders using fluorinated descarboethoxyloratadine |
WO2001045676A2 (en) * | 1999-12-20 | 2001-06-28 | Schering Corporation | Extended release oral dosage composition |
WO2001045668A2 (en) * | 1999-12-20 | 2001-06-28 | Schering Corporation | Stable extended release oral dosage composition comprising pseudoephedrine and desloratadine |
JP5592042B2 (en) * | 2000-04-14 | 2014-09-17 | ジェイ−メド ファーマシューティカルズ,インコーポレーティッド | Single dose antihistamine / decongestant formulation for the treatment of rhinitis |
PE20020055A1 (en) * | 2000-05-25 | 2002-02-12 | Schering Corp | STABLE LIQUID AND SOLID FORMULATIONS INCLUDING A NON-SEDATING ANTIHISTAMINE AND A NASAL DECONGESTANT |
MXPA03011705A (en) * | 2001-06-20 | 2004-03-19 | Schering Corp | Antihistamines for the treatment of nasal congestion and nasal obstruction. |
PL1896022T3 (en) * | 2005-06-17 | 2013-03-29 | Aft Pharmaceuticals Ltd | Novel pharmaceutical composition and its use in a method for treatment of patients with upper respiratory mucosal congestion |
NZ573174A (en) * | 2006-06-01 | 2012-01-12 | Msd Consumer Care Inc | Sustained release pharmaceutical dosage form containing phenylephrine |
AR061169A1 (en) * | 2006-06-01 | 2008-08-06 | Schering Plough Healthcare | PHARMACEUTICAL FORMULATIONS OF PHENYLPHERINE AND COMPOSITIONS FOR ABSORPTION IN THE COLON |
KR101540191B1 (en) * | 2014-02-24 | 2015-07-28 | 성균관대학교산학협력단 | Composition comprising Loratadine for anti-inflammation |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1110397A (en) * | 1964-10-02 | 1968-04-18 | Mead Johnson & Co | Ephedrine composition |
US4990535A (en) * | 1989-05-03 | 1991-02-05 | Schering Corporation | Pharmaceutical composition comprising loratadine, ibuprofen and pseudoephedrine |
US5407686A (en) * | 1991-11-27 | 1995-04-18 | Sidmak Laboratories, Inc. | Sustained release composition for oral administration of active ingredient |
US5314697A (en) * | 1992-10-23 | 1994-05-24 | Schering Corporation | Stable extended release oral dosage composition comprising loratadine and pseudoephedrine |
US5595997A (en) * | 1994-12-30 | 1997-01-21 | Sepracor Inc. | Methods and compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadine |
-
1997
- 1997-10-29 EP EP97912874A patent/EP0941091A1/en not_active Withdrawn
- 1997-10-29 PL PL97333056A patent/PL333056A1/en unknown
- 1997-10-29 SK SK545-99A patent/SK54599A3/en unknown
- 1997-10-29 JP JP10520579A patent/JP2000505104A/en active Pending
- 1997-10-29 TR TR1999/01003T patent/TR199901003T2/en unknown
- 1997-10-29 AU AU49953/97A patent/AU731756B2/en not_active Ceased
- 1997-10-29 NZ NZ335078A patent/NZ335078A/en unknown
- 1997-10-29 CZ CZ991509A patent/CZ150999A3/en unknown
- 1997-10-29 ID IDW990280D patent/ID23431A/en unknown
- 1997-10-29 AR ARP970105033A patent/AR008908A1/en not_active Application Discontinuation
- 1997-10-29 CA CA002268546A patent/CA2268546A1/en not_active Abandoned
- 1997-10-29 HU HU9904075A patent/HUP9904075A3/en unknown
- 1997-10-29 CN CN97199404A patent/CN1235545A/en active Pending
- 1997-10-29 WO PCT/US1997/019158 patent/WO1998018470A1/en not_active Application Discontinuation
- 1997-10-29 BR BR9712705-1A patent/BR9712705A/en not_active Application Discontinuation
- 1997-10-29 IL IL12966297A patent/IL129662A0/en unknown
- 1997-10-29 PE PE1997000968A patent/PE11399A1/en not_active Application Discontinuation
- 1997-10-29 ZA ZA9709731A patent/ZA979731B/en unknown
- 1997-10-29 CO CO97063641A patent/CO4910128A1/en unknown
- 1997-10-29 KR KR1019990703790A patent/KR20000052922A/en not_active Application Discontinuation
-
1999
- 1999-04-29 NO NO992062A patent/NO992062D0/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
NO992062L (en) | 1999-04-29 |
AU731756B2 (en) | 2001-04-05 |
CO4910128A1 (en) | 2000-04-24 |
KR20000052922A (en) | 2000-08-25 |
JP2000505104A (en) | 2000-04-25 |
AR008908A1 (en) | 2000-02-23 |
CZ150999A3 (en) | 1999-10-13 |
HUP9904075A3 (en) | 2002-02-28 |
CA2268546A1 (en) | 1998-05-07 |
CN1235545A (en) | 1999-11-17 |
ZA979731B (en) | 1998-04-29 |
PL333056A1 (en) | 1999-11-08 |
AU4995397A (en) | 1998-05-22 |
ID23431A (en) | 2000-04-20 |
HUP9904075A2 (en) | 2000-05-28 |
WO1998018470A1 (en) | 1998-05-07 |
EP0941091A1 (en) | 1999-09-15 |
NO992062D0 (en) | 1999-04-29 |
BR9712705A (en) | 1999-10-26 |
SK54599A3 (en) | 2000-08-14 |
TR199901003T2 (en) | 1999-07-21 |
IL129662A0 (en) | 2000-02-29 |
NZ335078A (en) | 2000-10-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PE11399A1 (en) | COMBINATION OF LORATADINE AND A DECONESCENTANT FOR THE TREATMENT OF ASTHMA | |
DE69721766D1 (en) | NEW MEDICAL FORMULATION | |
DE69400799D1 (en) | USE OF RILUZOL FOR THE TREATMENT OF PARKINSON AND THE PARKINSON SYNDROME | |
BR0008276A (en) | Combinations of formoterol and fluticasone propionate for asthma | |
DE60117615D1 (en) | MEDICINAL COMBINATIONS (FOR EXAMPLE CHLOROPROMAZINE AND PENTAAMIDINE) FOR THE THERAPY OF NEOPLASTIC DISEASES | |
ATE329608T1 (en) | FORMULATIONS OF COPOLYMER 1 (GLATIRAMER ACETATE) FOR ORAL, NASAL AND PULMONARY ADMINISTRATION | |
AR016798A1 (en) | USE OF A LACTOBACILLUS CEPA FOR THE PREPARATION OF A MEDICINAL PRODUCT | |
BRPI0108435B8 (en) | formulation and use of low-dose entecavir | |
NO990522L (en) | Use of <beta> -sheet mimetics as protease and kinase inhibitors of transcription factors | |
DE69932510D1 (en) | VASKULARISIERUNGSINHIBITOREN | |
NO20004419L (en) | New use | |
ATE291914T1 (en) | MEDICINAL COMPOSITIONS CONTAINING ZOLEMTRIPT | |
DE60002885D1 (en) | AQUEOUS FORMULATION FOR NASAL ADMINISTRATION | |
DE60214527D1 (en) | USE OF FLUMAZENIL IN THE DEVELOPMENT OF A MEDICAMENT FOR THE TREATMENT OF ALCOHOL DEPENDENCE | |
RS49599B (en) | Use of h+, k+ -atpaze inhibitors and glucocortifoids and pharmaceutical formulation | |
AR023687A1 (en) | A COMPOSITION FOR THE TREATMENT OF EXTERNAL RETINA DISORDERS AND THE USE OF A GLUTAMATE ANTAGONIST FOR THE MANUFACTURE OF A MEDICINAL PRODUCT FOR THE TREATMENT OF EXTERNAL RETINA DISORDERS | |
NO20013414D0 (en) | New use of melagatran | |
ATE271852T1 (en) | IMPROVED INHALATION PREPARATIONS | |
HUP0204097A2 (en) | Use of guanosine-3',5'monophosphate phosphodiesteraze-inhibitor for production of pharmaceutical compositions available for treatment of diabetic ulcers | |
NO990450L (en) | Treatment of mental disorders | |
BR0015781A (en) | Pharmaceutical composition for treatment of diseases associated with decreased bone mass | |
NO20032006D0 (en) | Use of melagatran for the manufacture of a medicament for the treatment of ischemic disorders | |
TR199901385T2 (en) | Piperidin t�revleri. | |
HUP9701606A2 (en) | Use of sulbutiamine to obtain pharmaceutical compositions useful in the treatment of certain psychomotor and psychointellectual disorders | |
BR0206918A (en) | Use of iloperidone |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC | Refusal |